Case report of west syndrome: a rare severe epilepsy in infants


Case report of west syndrome: a rare severe epilepsy in infants


G. Pravalika1, Sushanta Kr Das1 and Saurabh Gupta2* 

1Department of Pharm. D, CMR College of Pharmacy, Kandlakoya (V)-501 401, Hyderabad, India

2Department of Pharmacology, Indore Institute of Pharmacy, Rau pithumpur road-45331, Indore, Madhya Pradesh, India


International Journal of Hospital Pharmacy

West syndrome (WS) also known as infantile spasms, is severe form of epilepsy of early childhood was first describe in 1840s. WS presents with myoclonic-tonic seizures (spasms) characterized by flexor, extensor or mixed movements with distinct electroencephalogram (EEG) pattern of hypsarrthmia and psychomotor arrest. Prevalence rate is ~ 4.0 cases per 10,000 children. Peak age of beginning is between 3 and 7 months; onset after 18 months is rare. Recent guidelines from the American Academy of Neurology and the Child Neurology Society for medical treatment of WS, recommends that ACTH is probably effective and vigabatrin is possibly effective in cessation of spasms of hypsarrhythmia. Although discovered 160 years ago, still its diagnosis, assessment and management continue to create many challenges to health care professionals and affected families. In this case of a 3 yr old male child was admitted for long period of almost 2 months before being discharged. This case was confirmed early but due to its complexity it took long time to get complete resolve of situation. ACTH with Valproate was found to effective; though ACTH showed some reactions still it was considered the best available medicine for WS. In conclusion, early detection and referral to a pediatric neurologist for clinical evaluation and prompt effective treatment is strongly recommended as it may improve prognosis.


Free Full-text PDF


How to cite this article:
G. Pravalika, Sushanta Kr Das, Saurabh Gupta. CASE REPORT OF WEST SYNDROME: A RARE SEVERE EPILEPSY IN INFANTS.. International Journal of Hospital Pharmacy, 2017,2: 4. DOI:10.28933/pravalika-ijhp-2016


References:

1. West WJ: On a peculiar form of infantile convulsions. Lancet 1841, 1:724–725.
2. Commission on Pediatric Epilepsy of the International League Against Epilepsy: Workshop on infantile spasms. Epilepsia 1992, 33:195
3. Hrachovy RA, Frost JD: Severe encephalopathic epilepsy in infants: infantile spasms (West syndrome). In Pediatric Epilepsy: Diagnosis and Therapy. Edited by: Pellock JM, Bourgeois BF, Dodson WE, Nordli DR Jr, Sankar R. Demos Medical Publishing, New York, NY; 2008:249–268.
4. Paciorkowski AR, Thio LL, Dobyns WB: Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011, 45:355–367.
5. Webb DW, Fryer AE, Osborne JP: Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996,38:146–155.
6. Lux AL, Osborne JP: A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004, 45:1416–1428.
7. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al.: Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668–1681.
8. Ludvigsson P, Olafsson E, Sigurthardottir S, Hauser WA: Epidemiologic features of infantile spasms in Iceland. Epilepsia 1994, 35:802–805.
9. Seimes H, Spohr HL, Michael T, Nau H. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia (1988) 29:553–6010.1111/j.1528-1157.1988.tb03760.
10. Pratz JM, Garaizar C, Rua MJ, Garcia-Nieto ML, Madoz P. Infantile spasms treated with high doses of sodium valproate: initial response and follow-up. Dev Med Child Neurol (1991) 33:617–2510.1111/j.1469-8749.1991.tb14932.
11. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord (2007) 9:353.
12. Chamberlain MC. Nitrazepam for refractory infantile spasms the Lennox-Gastaut syndrome. J Child Neurol (1996) 11:31–410.1177/088307389601100107 .
13. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre randomised controlled trial. Lancet (2004) 364:1773–810.1016/S0140-6736(04)17400.
14. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord (2007) 9:353.